CG Oncology Inc. (CGON) vs MiniMed Group, Inc. Common Stock (MMED)

A side-by-side comparison of CG Oncology Inc. and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CG Oncology Inc. logo
CGON
CG Oncology Inc.
$5.86B
$66.40HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
MiniMed Group, Inc. Common Stock logo
MMED
MiniMed Group, Inc. Common Stock
$5.54B
$19.71HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — CGON vs MMED

growth of $100 · dividends reinvested · last 1y
CGON +11.0% (+11.0%/yr)MMED +9.0% (+9.0%/yr)CGON compounded faster over this window
6080100120Start $100$111$109
CGON MMED

CGON vs MMED: by the numbers

  • •CGON is the larger company ($5.86B vs $5.54B market cap).
  • •Both run net losses; MMED's is the smaller (-10.21% vs -3602.68% net margin).

Metrics side by side

Valuation

MetricCGONMMED
Forward P/EN/A29.27
P/S ratio940.441.72
P/B ratio5.691.53
EV / EBITDAN/A30.79

Profitability

MetricCGONMMED
Gross margin-15.02%53.85%
Operating margin-4722.13%0.53%
Net margin-3602.68%-10.21%
ROE-21.80%-9.09%
ROIC-24.33%0.43%

Go deeper

Full CGON analysisFull MMED analysisInteractive comparison tool

Dig into the metrics

CG Oncology ROEMiniMed Group, Inc. Common Stock ROECG Oncology operating marginMiniMed Group, Inc. Common Stock operating marginCG Oncology revenue growthMiniMed Group, Inc. Common Stock revenue growthCG Oncology free cash flowMiniMed Group, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.